Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Dia-Präsentation von Merck Gesellschaft mbH. Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen) Übersicht
| ||||||||||||||||||
Abbildung 19: Telmisartan - Perindopril Telmisartan 80 mg reduced mean DBP in the last 8 h of the dosing interval compared with perindopril 4 mg (P≤0.05).1 This study was a 6-week, double-blind, ABPM trial in 60 patients with mild-to-moderate hypertension. DBP control (24-h mean DBP <85 mmHg) was observed in 66.6% of telmisartan-treated patients but only 46.6% of perindopril-treated patients (P<0.05). 1. Nalbantgil I, et al. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension. Int J Clin Pract 2004; 58: 50–54. |
Abbildung 19: Telmisartan - Perindopril
Telmisartan 80 mg reduced mean DBP in the last 8 h of the dosing interval compared with perindopril 4 mg (P≤0.05).1 This study was a 6-week, double-blind, ABPM trial in 60 patients with mild-to-moderate hypertension. DBP control (24-h mean DBP <85 mmHg) was observed in 66.6% of telmisartan-treated patients but only 46.6% of perindopril-treated patients (P<0.05). 1. Nalbantgil I, et al. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension. Int J Clin Pract 2004; 58: 50–54. |